Masimo (MASI)
(Delayed Data from NSDQ)
$108.09 USD
-0.90 (-0.83%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $108.05 -0.04 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum C VGM
Masimo (MASI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$144.50 | $170.00 | $86.00 | 32.58% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Masimo comes to $144.50. The forecasts range from a low of $86.00 to a high of $170.00. The average price target represents an increase of 32.58% from the last closing price of $108.99.
Analyst Price Targets (6 )
Broker Rating
Masimo currently has an average brokerage recommendation (ABR) of 1.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.86 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, four are Strong Buy, representing 57.14% of all recommendations. A month ago, Strong Buy represented 57.14%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MASI.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.86 | 1.86 | 1.86 | 2.14 | 2.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/3/2024 | Piper Sandler | Jason Bednar | Hold | Strong Buy |
5/8/2024 | Needham & Company | Michael Matson | Hold | Hold |
5/8/2024 | Raymond James | Jayson T Bedford | Hold | Hold |
5/7/2024 | Not Identified | Not Identified | Hold | Hold |
4/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/25/2024 | Wells Fargo Securities | Vikramjeet S Chopra | Hold | Strong Buy |
3/25/2024 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.86 |
ABR (Last week) | 1.86 |
# of Recs in ABR | 7 |
Average Target Price | $144.50 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 100 of 252 |
Current Quarter EPS Est: | 0.77 |